ALL NEWS

FDA advisers unanimously recommend booster doses of Johnson & Johnson’s Covid-19 vaccine

Oct 15, 2021, 11:32 AM | Updated: 12:12 pm

FILE - In this April 13, 2021, file photo, a box of Johnson & Johnson vaccines are shown by pha...

FILE - In this April 13, 2021, file photo, a box of Johnson & Johnson vaccines are shown by pharmacist Zsolt Szenasi at a warehouse of Hungaropharma, a Hungarian pharmaceutical wholesale company, in Budapest, Hungary. Johnson & Johnson released data showing that a booster dose to its one-shot coronavirus vaccine provides a strong immune response months after people receive a first dose.i n a statement on Tuesday, Sept. 21, 2021, J&J said it ran two early studies in people previously given its vaccine and found that a second dose produced an increased antibody response in adults aged 18 to 55. The study results have not yet been peer-reviewed. (Szilard Koszticsak/MTI via AP, File)

(Szilard Koszticsak/MTI via AP, File)

    (CNN) — Vaccine advisers to the US Food and Drug Administration voted unanimously Friday to recommend a booster dose of Johnson & Johnson’s vaccine at least two months after people get the first dose.

The FDA’s Vaccines and Related Biological Products Advisory Committee voted 19-0 to recommend the extra dose for all recipients of the J&J Janssen vaccine, 18 and older. They asked to simplify the original question being posed by the FDA, which had asked the committee to say whether the data showed that waiting six months or longer after getting the first shot would provide an even stronger immune response.

The FDA will now consider the committee’s advice. Then the US Centers for Disease Control and Prevention’s vaccine advisers will be asked to consider it.

Johnson & Johnson says studies have shown boosting at two or six months can bring that effectiveness up to 94% and it says its effectiveness does not wane over time in the same way that effectiveness from Pfizer’s vaccine does.

But the Johnson & Johnson vaccine has not been shown to be as protective as either the Pfizer or Moderna vaccines, noted VRBPAC chair Dr. Arnold Monto, a professor of public health and epidemiology at the University of Michigan. “So there is some urgency here to do something,” he told the meeting.

And the CDC’s Dr. Amanda Cohn told the meeting that various studies suggested real-world efficacy of J&J’s vaccine was anywhere between 50% and 68%.

“Regardless of whether or not there been waning or this is the true effectiveness after a single dose, the effectiveness or protection of a single dose of the J&J vaccine is not equivalent to protection at this time with either two doses of an mRNA vaccine and certainly not in those groups who have now been authorized to receive a booster dose of an mRNA vaccine,” Cohn said.

Members of the committee said while there was not much data to show whether the efficacy of the Janssen vaccine was waning — or was strong to begin with — they agreed people should be given the opportunity for a booster. “I would say I agree a second dose booster is needed to boost immunity back to the 90-plus range,” Dr. Archana Chatterjee, a pediatric infectious diseases expert at Rosalind Franklin University in Chicago, said before the vote.

The FDA has already given EUA to a booster for Pfizer’s vaccine for people who are six months out from their first two shots who are also either 65 or older or who are at least 18 and have a higher risk of severe disease because of pre-existing conditions or because of work or living conditions.

And Americans are already flocking to get those boosters. Data from the US Centers for Disease Control and Prevention show close to 5% of fully vaccinated people — about 9 million people — have received booster shots.

On Thursday, VRBPAC members voted unanimously to recommend booster doses of Moderna’s vaccine to the same groups.

If the FDA gives emergency use authorization to Moderna or Johnson & Johnson boosters, CDC vaccine advisers will meet to discuss which groups to recommend them to. Typically, shots can be administered once the CDC director signs off on the recommendation. CDC’s Advisory Committee on Immunization Practices is scheduled to discuss boosters on October 21.

The-CNN-Wire
™ & © 2021 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.

We want to hear from you.

Have a story idea or tip? Send it to the KSL NewsRadio team here.

All News

The steel frame of the Francis Scott Key Bridge sits on top of the container ship Dali after the br...

Nick Perry

Baltimore bridge collapse puts the highly specialized role of ship’s pilot under the spotlight

The highly specialized role — in which a pilot temporarily takes control of a ship from its regular captain — is coming under the spotlight this week.

2 hours ago

Shopping carts are parked outside a Home Depot in Philadelphia...

MICHELLE CHAPMAN AP Business Writer

Home Depot buying supplier to professional contractors in a deal valued at about $18.25 billion

Home Depot will buy SRS Distribution, a materials provider for professionals, in a deal valued at approximately $18.25 billion.

3 hours ago

Killer Mike poses in the press room with three trophies he won at the 66th annual Grammy Awards on ...

Carter Williams, KSL.com

Recent Grammy winners highlight Ogden Twilight Concert Series lineup

Hip hop star Michael Render, known by his stage name Killer Mike, fresh off of three Grammy Award wins last month, is one of several musical artists set to headline this year's Ogden Twilight Concert Series.

4 hours ago

"Burn Book," by longtime Silicon Valley reporter Kara Swisher is seen, Friday, Feb. 23, 2024, in Sa...

Jeff Caplan

Jeff Caplan’s Minute of News: Telling tales about tech bros

Kara Swisher’s new book paints an ugly picture of Silicon Valley.

6 hours ago

pets...

Curt Gresseth

Don’t surrender pets to a shelter. Send in a pro to reverse bad behavior, says Utah trainer

An expert discusses controlling the unwanted behavior of pets.

6 hours ago

Exclusive video obtained by KSL NewsRadio shows Salt Lake hit-and-run in the Avenues neighborhood. ...

Eric Cabrera

WATCH: Exclusive video shows woman survives Salt Lake City hit and run

KSL NewsRadio has exclusively obtained footage of a Salt Lake City hit-and-run, where a woman was struck while out for a run in the Avenues.

6 hours ago

Sponsored Articles

Mother and cute toddler child in a little fancy wooden cottage, reading a book, drinking tea and en...

Visit Bear Lake

How to find the best winter lodging in Bear Lake, Utah

Winter lodging in Bear Lake can be more limited than in the summer, but with some careful planning you can easily book your next winter trip.

Happy family in winter clothing at the ski resort, winter time, watching at mountains in front of t...

Visit Bear Lake

Ski more for less: Affordable ski resorts near Bear Lake, Utah

Plan your perfect ski getaway in Bear Lake this winter, with pristine slopes, affordable tickets, and breathtaking scenery.

front of the Butch Cassidy museum with a man in a cowboy hat standing in the doorway...

Bear Lake Convention and Visitors Bureau

Looking Back: The History of Bear Lake

The history of Bear Lake is full of fascinating stories. At over 250,000 years old, the lake has seen generations of people visit its shores.

silhouette of a family looking over a lake with a bird in the top corner flying...

Bear Lake Convention and Visitors Bureau

8 Fun Activities To Do in Bear Lake Without Getting in the Water

Bear Lake offers plenty of activities for the whole family to enjoy without having to get in the water. Catch 8 of our favorite activities.

Wellsville Mountains in the spring with a pond in the foreground...

Wasatch Property Management

Advantages of Renting Over Owning a Home

Renting allows you to enjoy luxury amenities and low maintenance without the long-term commitment and responsibilities of owning a home.

Clouds over a red rock vista in Hurricane, Utah...

Wasatch Property Management

Why Southern Utah is a Retirement Paradise

Retirement in southern Utah offers plenty of cultural and recreational opportunities. Find out all that this region has to offer.

FDA advisers unanimously recommend booster doses of Johnson & Johnson’s Covid-19 vaccine